MemoHive prints every dose — and four of its five sit below the studied range. 540 mg of the 1,030 mg is a sports ingredient. MemoHive sale from $49. Claim it
40 articles

Ingredient Evidence

Bacopa, rhodiola, L-theanine, ginseng and BCAA: what each is studied for, at what dose, and what that research does not establish.

Ingredient Evidence

Lion's Mane and Nerve Growth Factor

Lion's mane mushroom is studied for possible stimulation of nerve growth factor, with small human trials and typical doses of 1–3 grams

2 September 2026Read →
Ingredient Evidence

B Vitamins, Homocysteine and Cognition

B vitamins lower homocysteine, and elevated homocysteine is associated with cognitive decline — but supplementing in people without def

26 August 2026Read →
Ingredient Evidence

Omega-3s and the Brain

Omega-3 fatty acids, particularly DHA, are structural components of brain cell membranes, though supplement trials for cognition in hea

19 August 2026Read →
Ingredient Evidence

Choline and Acetylcholine: The Theory

Acetylcholine is a neurotransmitter involved in memory, and choline is its dietary precursor — the reasoning behind choline-containing

5 August 2026Read →
Ingredient Evidence

Adaptogens: What the Word Actually Means

“Adaptogen” describes plants claimed to help the body resist stress, a category term from mid-century research rather than a regulated

22 July 2026Read →
Ingredient Evidence

BCAAs and the Blood-Brain Barrier

Branched chain amino acids share a transport system with tryptophan and tyrosine at the blood-brain barrier, so large intakes can in pr

15 July 2026Read →
Ingredient Evidence

Panax Ginseng and Cognition: A Mixed Record

Panax ginseng has been studied for mental performance and fatigue at 200–400 mg daily of standardised extract, with reviews reporting i

24 June 2026Read →
Ingredient Evidence

L-Theanine and Calm, Focused Attention

L-theanine is an amino acid from tea studied for calm, focused attention, at doses spanning roughly 100–400 mg, with 200 mg common in a

10 June 2026Read →
Ingredient Evidence

Comparing Two Products' Ingredient Lists

A fair comparison matches serving size, ingredient form, standardisation and amount — not just the ingredient names or the headline tot

10 June 2026Read →
Ingredient Evidence

Serving Size Is Not One Capsule

Supplement Facts amounts are given per serving, and a serving is often two or more capsules — so per-capsule content is a fraction of t

3 June 2026Read →
Ingredient Evidence

Rosavins vs Salidroside: The Rhodiola Detail

Most well-known rhodiola trials used an extract standardised to roughly 3% rosavins and about 1% salidroside; a product standardised on

3 June 2026Read →
Ingredient Evidence

Rhodiola Rosea and Mental Fatigue

Rhodiola rosea is studied for mental fatigue and performance under stress, generally at 200–600 mg daily of a standardised extract.

27 May 2026Read →
Ingredient Evidence

Fillers, Flow Agents and Capsule Materials

The “other ingredients” line lists capsule material, fillers and flow agents — usually inert, occasionally relevant for allergies or di

27 May 2026Read →
Ingredient Evidence

Why Bacoside Standardisation Matters

Bacopa's activity is attributed to compounds called bacosides, and research extracts are standardised to a stated bacoside percentage —

20 May 2026Read →
Ingredient Evidence

Dietary Sources vs Supplement Forms

Nutrients from food arrive with co-factors and in different chemical forms than isolated supplements, which sometimes changes how they

13 May 2026Read →
Ingredient Evidence

Combination Effects Are Rarely Studied

Multi-ingredient formulas assume their components work together, but interactions between botanicals in a blend are almost never tested

6 May 2026Read →
Ingredient Evidence

Why Healthy Adults Show Smaller Effects

Supplements often show clearer effects in people with a deficiency or impairment, and much smaller ones in healthy adults who have less

29 April 2026Read →
Ingredient Evidence

Publication Bias in Supplement Research

Positive results are more likely to be published than negative ones, which makes the visible literature on any ingredient look more fav

22 April 2026Read →
Ingredient Evidence

Effect Size: The Number Nobody Quotes

A statistically significant result can still be too small to notice; effect size describes how large the change actually was, and it is

15 April 2026Read →
Ingredient Evidence

Preclinical, Animal and Human Evidence

Cell-culture experiments, animal models and human trials answer different questions, and results at one level do not establish outcomes

8 April 2026Read →
Ingredient Evidence

Search-Link Citations Are Not Evidence

Some pages cite a database search results page rather than a specific study, which points at a body of literature without committing to

1 April 2026Read →
Ingredient Evidence

Reading a Supplement Citation Properly

A useful citation check asks four questions: what dose, what population, what endpoint, and what form of the ingredient was used.

25 March 2026Read →
Ingredient Evidence

Why Finished-Product Trials Are So Rare

Testing a complete multi-ingredient formula in a randomised trial is expensive and commercially risky, which is why almost every supple

18 March 2026Read →
Ingredient Evidence

Whole Herb vs Extract: What Changes

Whole powdered herb and a concentrated extract are different materials: the extract contains more of certain compounds per gram, but no

11 March 2026Read →
Ingredient Evidence

Why Extract Ratios Are Not Doses

A ratio such as 10:1 describes how much raw herb was concentrated into the extract; it does not tell you how much you are taking or how

25 February 2026Read →
Ingredient Evidence

Curcumin and Its Absorption Problem

Curcumin from turmeric is a genuine antioxidant with poor oral bioavailability, which is why research formulations pair it with piperin

18 February 2026Read →
Ingredient Evidence

Huperzine A and the Dose Problem in Reverse

Huperzine A is active at microgram doses and works by inhibiting an enzyme that breaks down acetylcholine, which makes both its potency

11 February 2026Read →
Ingredient Evidence

Ashwagandha, Stress and Cognitive Claims

Ashwagandha is studied mainly for stress and anxiety measures at 300–600 mg daily of standardised root extract, with cognitive claims r

4 February 2026Read →
Ingredient Evidence

Creatine and Cognition: An Emerging Area

Creatine, best known in sports nutrition, has emerging research on cognition particularly under sleep deprivation or in vegetarians, at

28 January 2026Read →
From $49 / bottle
60-day guarantee · free US shipping on 3 & 6
Order MemoHive